Companies in
Research & Development

Chemoforma AG

Research & Development · Augst Bl · Since 1966

Chemoforma AG develops and manufactures natural complementary feed products for livestock and companion animals and supplies products for aquaculture. The company is GMP+ and ISO 9001 certified and markets product lines such as ASCOGEN®, VANNAGEN®, BIORACING® and ASCOSAN®.

ChondroNest SA

Research & Development · Conthey · Since 2015

ChondroNest SA develops a patented composition of modified biopolymers from the extracellular matrix designed to reconstruct cartilage. The technology is a surgeon-placeable, shapeable paste that solidifies under biocompatible conditions to reconstruct the ECM scaffold in vivo; the company is pursuing preclinical studies toward applications in hyaline cartilage repair.

CHoNova AG

Research & Development · Oberhasli · Since 2024

The core activity of ChoNova AG is the development and application of additive manufacturing (3D printing) in the food industry, particularly in the field of chocolate production. The company develops innovative solutions such as the DetachLog device and works on optimizing processes in food production.

CIPEL Distribution SA

Research & Development · Pfyn · Since 2024

CK-CARE AG

Research & Development · Davos Wolfgang · Since 2002

The core activity of CK-CARE is the research and development of therapies for rare diseases, particularly atopic dermatitis (neurodermatitis), through high-quality research in a scientific network in the field of allergology. The company focuses on collecting and evaluating data and samples in a biobank to enable a better understanding of complex diseases and develop innovative therapies and prevention strategies.

CleverCity GmbH

Research & Development · Wetzikon Zh · Since 2020

The core activity of CleverCity is the development and implementation of products and solutions in the Smart City and Smart Energy sectors, particularly in intelligent street lighting control and load management applications. The company offers customer-specific solutions, applications, and hardware and firmware developments, and has a network of specialists in the lighting industry.

Clinical Drug Development Consulting AG

Research & Development · Flüh · Since 2013

The core activity of Clinical Drug Development Consulting AG (Ltd) is the consulting and support of companies in the clinical development of drugs, particularly in the early stages of development (first-in-human studies and proof-of-concept studies). This also includes services such as clinical pharmacology studies, early patient studies, and clinical development (Phase I-IV). The company also offers interim executives such as Chief Medical Officer, Chief Safety Officer, and Chief Pharmacovigilance Officer.

CLINIQUE PODERM SARL

Research & Development · Carouge Ge · Since 2022

The core activity of PODERM is the development of products and methods for the treatment of foot and nail diseases.

CME SWISS AG

Research & Development · Bichwil · Since 2006

The core activity of CME Swiss AG is the development and production of cloud-based analytical systems, particularly the KME-ERI system, which is designed for integrative medicine and health promotion. The company offers a screening system that evaluates the health status of the human body and enables targeted measures for health promotion and preservation. In addition, the company provides training, consulting, and support for users of the system to ensure effective application of the technology.

Coat-X SA

Research & Development · La Chaux-De-Fonds · Since 2016

The core activity of Coat-X is the development and application of thin-film encapsulation technologies, particularly Parylene coatings, to protect sensitive components in various industries such as medical technology, industry and watchmaking. The company offers specialized coating services and products, such as CX-PROTECT, CX-Ultra, CX-ULTIMA and CX-LOTUS, to protect products from harsh environmental conditions.

Combioxin SA

Research & Development · Epalinges · Since 2015

The core activity of Combioxin SA is the development of life-saving medications for severe infections, particularly for the treatment of severe bacterial pneumonias. The company focuses on the development of innovative therapeutics, such as CAL02, a first-in-class anti-toxin agent used to neutralize virulence factors that play a crucial role in the development of organ failure and fatal complications in severe infections.

Combivap AG

Research & Development · Buchs Sg · Since 2011

Combivap AG provides combinatorial screening and optimization of organic materials and OLED devices, supplies customized OLED elements, and offers consulting services in organic electronics and vacuum technology.

Combo Labs GmbH

Research & Development · Zurich · Since 2022

CompagOs AG

Research & Development · Hünenberg · Since 2023

CompagOs AG develops the Bon3OID™ biohardware platform, which integrates engineered 3D‑bioprinted bone‑like tissue constructs with hardware for controlled mechanical loading to produce functional, multi‑modal readouts. The platform supports preclinical New Approach Methodologies (NAMs) and translational diagnostics research by enabling efficacy assessment and mechanistic insight in bone‑focused programs.

Conmetec GmbH

Research & Development · Hagenbuch Zh · Since 2016

The core activity of Conmetec GmbH is the development and distribution of sensors and measuring devices, particularly in the field of tank storage, as well as consulting and supporting start-ups in the technology sector.

ConReha GmbH

Research & Development · Forch · Since 2016

The core activity of ConReha GmbH encompasses scientific consulting services in the field of Physical Rehabilitation, particularly: Research services in the field of Clinical Sciences, Research and Development in the field of Prosthetics and Orthotics, Assessments and evaluations for users of Prosthetic and Orthotic devices, Continuous training in the field of technical orthopedic devices.

Consult AG Statistical Services

Research & Development · Zurich · Since 1971

Consult AG Statistical Services provides statistical consulting and services for the planning, conduct and analysis of statistical projects. Services include methodological analyses (e.g. linear and generalized models, mixed models, nonparametric and sampling methods, multivariate and simulation-based approaches) and custom programming in R, SAS or Excel, with applications in real estate, healthcare, transport, logistics and lotteries.

Contelec SA

Research & Development · Brügg Be · Since 1966

The Contelec AG company develops and manufactures high-precision measurement instruments and sensors for various industries, particularly for agricultural technology, rail technology, construction machinery, energy, heating, climate and ventilation, joystick, marine, medical, mobile vehicles and motor feedback. The company's core activity lies in the development and production of rotary encoders, potentiometers and other measurement instruments required for the precise capture of angle and distance measurements.

Copexis SA

Management Consulting · La Conversion · Since 2004

The core activity of Copexis S.A. is consulting and supporting pharmaceutical development, particularly in the following areas: * Early-stage pharmaceutical development (from development candidate to clinical phase II) * Late-stage pharmaceutical development (clinical phase III and marketing authorization in Europe and Switzerland) * Strategic consulting and support for the implementation of solutions in the areas of: + Pharmaceutical manufacturing + Toxicology + Clinical trials + Regulatory affairs * Regulatory services (CH/EU) * Corporate development and management Copexis positions itself as a strategic partner for companies in the pharmaceutical industry, offering comprehensive consulting and support for pharmaceutical development.

Cord Blood Center AG

Research & Development · Lucerne · Since 2016

Cord Blood Center AG offers intravenous infusions of umbilical cord blood cells for ischemic stroke recovery in cooperation with partner clinics. Services include patient support (including a medical concierge) and references to published clinical trials on cord blood treatments.

CoreQuest Sagl

Research & Development · Lugano · Since 2008

CoreQuest Sagl is a pharmaceutical company conducting research and development of pharmaceutical products and medical devices in nephrology and surgical areas. It develops biocompatible hypertonic solutions for peritoneal dialysis, designs devices and monitoring techniques for dialysis patients, and pursues research programs addressing chronic renal failure and congestive heart failure, including a peritoneal ultrafiltration platform (Polycore).

CORESO - Collaborative Research Solutions Sàrl

Research & Development · Dully · Since 2020

CORESO - Collaborative Research Solutions Sàrl provides research and consulting services focused on stakeholder collaboration and a systemic approach to addressing complex problems. The firm performs quantitative analyses, applies collective-intelligence methods and develops web tools and applied research projects such as the GenEqSim equality simulator and the CORESO-Tool.

CORETAG Therapeutics AG

Research & Development · Basel · Since 2020

The core activity of Coretag is the development of therapeutics for the treatment of cancer, particularly through the development of platforms for targeted tumor treatment. The company focuses on developing innovative solutions to improve treatment outcomes and the quality of life for cancer patients.

Cosmetic Consulting JW & Partner Sagl

Research & Development · Locarno · Since 2010

Cosmetic Consulting JW & Partner Sagl develops and formulates skincare and haircare products, cosmeceuticals and eco-cosmetics. The company provides scientific research, formula development, packaging design, quality assurance, regulatory documentation (safety assessment, product information file) and support with CPNP registration, as well as production coordination and product launch services.

Cosmoscience SA

Research & Development · Aigle · Since 1974

The core activity of Laboratoires CosmoScience is the research and development of non-invasive medical aesthetic products, particularly in the fields of medical cosmetology, aesthetic mesotherapy and hyaluronic acid fillers.

Crealac Sàrl

Research & Development · La Chaux-De-Fonds · Since 2022

The core activity of Crealac Sàrl is the development and manufacturing of formulations for DILUTIFS (thinners) and VERNIS (varnishes) for various application areas.

Crema Vermögensverwaltung & Research GmbH

Research & Development · Zurich · Since 2007

The core activity of the company CREMA (Center of Research in Economics, Management and the Arts) is the conduct of research and publications in the fields of economics, management and art.

C Research AG

Research & Development · St. Gallen · Since 2017

The core activity of C Research AG is the conduct of economic research and consulting, particularly in the field of aviation.

CRISPR Therapeutics AG

Research & Development · Zug · Since 2013

The core activity of CRISPR Therapeutics is the development of gene therapeutic medicines, particularly through the application of CRISPR-Cas9 technology, to cure diseases at the molecular level. The company focuses on developing medicines for various diseases such as sickle cell anemia, β-thalassemia, cancer, autoimmune disorders, and regenerative medicine.

Cross-border Research Association

Research & Development · Epalinges · Since 2005

The core activity of TAPA EMEA is to improve supply chain security, particularly by connecting experts and developing educational materials to support companies in securing their supply chains.

Cross Research SA

Research & Development · Arzo · Since 1997

The core activity of CROSS Research SA is the conduct of clinical trials, particularly Phase I trials, for the pharmaceutical industry. The company offers services such as central clinical laboratories, analytical laboratories for drug analysis and pharmaceutical laboratories for the development of drugs. It also conducts safety studies, dose-finding studies, bioavailability and bioequivalence studies, as well as specialized studies such as skin adhesion studies and medical device testing.

cryoWrite AG

Research & Development · Basel · Since 2023

The core activity of cryoWrite is the development and manufacture of systems for automated cryo-electron microscopy (cryo-EM) sample preparation. The company focuses on accelerating structure-based drug development by improving the workflow for determining protein structure and enabling new analytical methods.

Cserv GmbH

Research & Development · St. Gallen · Since 2022

The core activity of Cserv is the application of cryogenic technology, i.e. the low-temperature treatment of materials and products to sustainably improve and optimize their properties. This includes the treatment of materials and components in various industries such as mechanical engineering, toolmaking, aerospace, automotive, motor sports, electrical engineering and food technology.

CSL Behring Lengnau AG

Research & Development · Lengnau Be · Since 2017

CSL Behring Lengnau AG is a biotechnology company that develops and manufactures biotherapeutics, including plasma-derived and recombinant products. It focuses on treatments for rare and serious diseases—such as immunoglobulins, specific immunoglobulins and albumin—and conducts research, production and pharmacovigilance activities.

CTI Clinical Trial and Consulting Services Switzerland GmbH

Research & Development · Zurich · Since 2022

CTI Clinical Trial and Consulting Services Switzerland GmbH is a contract research organization (CRO) providing clinical development and consulting services, including study design, clinical project management, monitoring, medical monitoring, and safety/pharmacovigilance. Its services also include laboratory offerings (bioanalytical, biorepository, safety testing), real‑world evidence and late‑phase studies, and a research center conducting Phase I–IV trials.

Strategic Foresight Management GmbH

Research & Development · Aarau · Since 2022

Curtis Instruments AG

Research & Development · Biberist · Since 1996

Curtis Instruments, Inc. is a leading provider of electric vehicle technology, integrated EV systems, and engineering services. The company's core activity is the development, manufacture, and marketing of motor controllers, instruments, power conversion products, and other components for electric vehicles, particularly in the field of electromobility.

Worx Digital People Solutions AG

Research & Development · Zurich · Since 2007

Worx Digital People Solutions AG operates a digital talent platform that turns feedback into continuous employee development. The solution includes multi‑source continuous feedback, personalised action plans and analytics, recruitment assessment tools (questionnaires and ability tests) and integrations such as Microsoft Active Directory.

Cylenk S.A.

Research & Development · Ursy · Since 1982

The core activity of Cylenk is to provide tailored research and development (R&D) services, particularly in the fields of mechatronics, IoT development and IoT cybersecurity. The company supports customers in developing innovative solutions, from idea generation to implementation, and offers flexible capacities to supplement internal teams or act as a complete external partner.

DAC System SA

Research & Development · Manno · Since 2022

The core activity of DAC System is the development and manufacture of solutions for monitoring and controlling radio transmission systems, particularly in the field of broadcasting and critical communication. The company offers specialized products and services to improve the reliability and efficiency of radio transmission systems, including solutions for monitoring antennas, power measurement and predictive maintenance.

DalCor Pharma UK Ltd., Leatherhead, Zweigniederlassung Zug

Research & Development · Zug · Since 2015

The core activity of DalCor Pharmaceuticals is the development and research of medicines for the treatment of cardiovascular diseases, particularly through the application of precision medicine. The company focuses on developing therapies to combat the world's largest health burden, cardiovascular diseases.

DAMIAN PHARMA AG

Research & Development · Walchwil · Since 2014

The core activity of DAMIAN PHARMA AG is the development and marketing of pharmaceutical products, in particular the development of therapies for rare diseases such as Primary Aldosteronism (PA).

Dandelion Science Sàrl

Research & Development · Geneva · Since 2023

The core activity of Dandelion Science is the development of a platform for Generative Neuromodulation, aiming to treat the brain by programming network dynamics, particularly in the treatment of brain injuries and diseases.

Data2time Sàrl

Research & Development · Geneva · Since 2025

Data2time Sàrl is a life data science consultancy that performs data‑driven exploratory analyses and offers algorithm and method prototyping. Services also include setting up data governance and data protection frameworks, quality management systems, development of analysis and reporting pipelines, critical reviews of clinical documents and trainings.

Datacie SA

Research & Development · Lausanne · Since 2020

The core activity of Datacie is the creation of customized, unique and proprietary datasets for companies. To this end, data is collected, extracted and processed from various sources such as corporate websites, news/press releases, legal/patent/trademark databases and regulatory databases. The data is processed using artificial intelligence and human quality assurance to create high-quality and accurate datasets. These datasets can then be used by companies to improve their products and services, open up new markets or optimize existing ones.

Davos Alzheimer's Collaborative (Genève)

Research & Development · Geneva · Since 2021

The core activity of Davos Alzheimer's Collaborative (DAC) is to mobilize a global partnership to combat Alzheimer's disease. This includes, in particular: Improving the early detection and diagnosis of Alzheimer's disease through innovative technologies and research; Preparing health systems worldwide for the introduction of new therapies and treatment methods; Conducting clinical trials and research programs; Collaborating with organizations, governments, and NGOs to promote Alzheimer's research and combat. DAC focuses specifically on developing programs and initiatives that improve the early detection and diagnosis of Alzheimer's disease, such as the Accurate Diagnosis Program and the Early Detection Program.

Davos BioSciences AG

Research & Development · Davos Wolfgang · Since 2019

The core activity of Davos BioSciences AG is to provide biobanking and laboratory services to pharmaceutical companies, particularly in the area of discovery and development of new therapeutic active ingredients and biomarkers, as well as the validation of markers and products to meet regulatory requirements. The focus is on inflammatory skin diseases, allergic diseases and disorders of the immune system, particularly in the field of precision medicine.